PDCD1 and neoplasm: Consequently, anti CTLA-4 and anti-PD-1/L1 have been established in multiple tumor types such as melanoma, lung cancer, urothelial carcinoma, renal cell carcinoma, esophagogastric cancer, and MSI-high colorectal cancer [23,24,25,26,27,28,29].